Liquid Biopsy Market Size Worth USD 5.53 Billion in 2028 - PowerPoint PPT Presentation

About This Presentation

Liquid Biopsy Market Size Worth USD 5.53 Billion in 2028


Surge in number of cancer patients and rise in preference for minimally invasive procedures are some key factors driving liquid biopsy market revenue growth – PowerPoint PPT presentation

Number of Views:0
Date added: 29 June 2022
Slides: 13
Provided by: data23


Transcript and Presenter's Notes

Title: Liquid Biopsy Market Size Worth USD 5.53 Billion in 2028

Liquid Biopsy Market Size Worth USD 5.53 Billion
in 2028
Surge in number of cancer patients and rise in
preference for minimally invasive procedures are
some key factors driving liquid biopsy market
revenue growth
Our Model
Market Analysis
Financial Analysis
Distribution Channel Analysis
Brand Analysis
Custom Market Intelligence
Competitor Analysis
Product Analysis
Custom Research
Demand Analysis
Risk Analysis
Business Plan Parameters
End Use Analysis
Demand Availability Analytics
Market Entry Strategy
Restructuring Revival
New Product Strategy
Product Planning / Strategy
SWOT Analysis
Marketing / Distribution Channel Feasibility
Customer Identification Survey
Competitive Landscape / MA Feasibility
Industries We Cater to
Market Summary
The global liquid biopsy market size is expected
to reach USD 5.53 Billion in 2028 and register a
steady revenue CAGR of 20.8 during the forecast
period, according to latest analysis by Emergen
Research. Rise in demand for early detection of
cancer is a key factor driving global liquid
biopsy market revenue growth. Liquid biopsy is a
safe and popular procedure carried out during
examination of cancer. The procedure is easy and
minimally invasive, allows early detection and
diagnosis of cancer, and helps in identification
of cancer treatment. Surge in preference for
non-invasive procedures is driving private and
public funding to support research activities in
the liquid biopsy field. Liquid biopsies allow
medical professional to discover various aspects
of a tumor through a patients blood sample. It
facilitates medical professionals to understand
which treatments are suitable for which
patients. Development of liquid biopsy has led
to a better understanding of molecular
diagnostics of circulating tumor DNA. Increased
adoption of liquid biopsy in cancer is due to its
potential of non-invasive detection of targeted
genomic alteration in correspondence to targeted
therapy. Non-cancerous application of liquid
biopsy includes diagnosis of heart attack, and
atherosclerosis. Advancements in next-generation
sequencing for patients with advanced stages of
cancer is also driving market growth.
Market Summary
  • Some Key Highlights from the Report
  • Assay Kits segment accounted for largest revenue
    share in 2020 due to increasing demand for liquid
    biopsy tests. High demand for these assays in
    hospitals and cancer clinics for early diagnosis
    is driving revenue growth of this segment.
  • Circulating Tumor DNA (ctDNA) segment accounted
    for a significantly large revenue share in 2020
    as liquid biopsy based on ctDNA analysis has shed
    new light on monitoring of cancer and molecular
    diagnostics. Liquid biopsy based ctDNA testing
    opens doors to potential uses such as analysis of
    effectiveness of cancer treatment, early
    detection and screening of primary cancer or
    recurrence, and identification of
    treatment-resistant genetic variations.
  • Hospitals and physician laboratories segment
    accounted for largest revenue share in 2020 due
    to high number of cancer cases registered in
    hospitals. Emergence of cancer specialty
    hospitals in developing countries with
    availability of advanced procedures such as
    liquid biopsy are driving revenue growth of this
    segment. Wide application of liquid biopsy across
    physician laboratory settings is also
    contributing to growth of this segment.
  • To get the sample link _at_https//www.emergenresearc
Market Summary
Emergen Research has segmented the global liquid
biopsy market on the basis of product,
circulating biomarkers, sample type, disease,
application, end-use, and region Product Outlook
(Revenue, USD Billion 20182028) Assays
Kits Instruments Services Circulating Biomarkers
Outlook (Revenue, USD Billion 20182028) Circulat
ing Tumor DNA (ctDNA) Circulating Tumor Cells
(CTCs) Extracellular Vesicles (EVs) Cell-Free DNA
(cfDNA) Other Circulating Biomarkers Sample Type
Outlook (Revenue, USD Billion 20182028) Blood
Sample based Urine Sample based Other Bio Fluids
based ReadMore_at_ https//
Parameter Details
Market Size Estimation Period 2020-2028
Base Year Considered 2020
Historical Data 2017-2019
Forecast Period 2021-2028
Quantitative Units Revenue in USD million CAGR from 2020 to 2028
Segments Covered Types, Application, End-Users, Regions more.
Countries Included The U.S., Germany, U.K., Italy, China, India, Japan, Brazil
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Regions Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Customization Scope 10 hours of free customization expert consultation
Pricing and Purchase Options Explore Different Purchase Options Request for Discount to Avail New Year Discount
Regional Share Dynamics
Latest published reports from the Healthcare
Sector by Emergen Research Clinical Decision
Support Systems (CDSS) Market_at_ https//www.emergen
port-systems-cdss-market Cancer Immunotherapy
Market_at_ https//
eport/cancer-immunotherapy-market Blockchain in
Healthcare Market_at_ https//
Biologics Market_at_ https//
industry-report/biologics-market Alternative
Proteins Market_at_ https//
About Us
At Emergen Research, we believe in advancing with
technology. We are a growing market research and
strategy consulting company with an exhaustive
knowledge base of cutting-edge and potentially
market-disrupting technologies that are predicted
to become more prevalent in the coming
decade. Our expertise umbrellas the
technological environment of all major
industries, and our services help you map your
actions to ensure optimal yield. Our analysts
utilize their market proficiency to offer
actionable insights that help our clients
implement profitable strategies and optimize
their return on investment. Our services are
wide-ranging, right from technological
environment analysis to technological profiling
that highlights the existing opportunities in the
market you can capitalize on to stay ahead of
your competitors.
Lets Talk Contact Information
Reach out to us and our Research Executives will
ensure you get the report that meets all your
requirements and address all your concerns.
14671 110 Avenue, Surrey, British Columbia, V3R2A9
1 (604) 757-9756
Write a Comment
User Comments (0)